Clinical trial Recruiting at 1 site Interventional Ages 50 to 70

Digital jaw tracking for full-arch maxillary implant restorations

Official title: Jaw Tracking Impact on Occlusion and Patient Outcomes in Maxillary Implant Restorations: Randomized Clinical Trial

Run by Mansoura University · NCT07693946 · Data updated 2026-11-12

This randomized trial tests whether using digital jaw tracking to guide the fabrication of full-arch maxillary implant-supported prostheses improves occlusal accuracy and patient satisfaction compared with a conventional workflow.

Quick facts

Study typeInterventional
Ages50 Years to 70 Years
SexAll
Enrollment20 (estimated)
SponsorMansoura University
Academic / other
Locations1 site (Al Mansurah, Dakahlia Governorate)
StatusRecruiting
StartedDecember 25, 2025
Main results expectedDecember 25, 2026
Study endsJanuary 25, 2027
Registry record updatedJuly 9, 2026
Trial IDNCT07693946 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 50–70 with a completely edentulous maxillary arch opposing natural dentition and good oral hygiene.

Probably not a fit

Patients with systemic conditions affecting bone healing or poor compliance may not benefit from the digital workflow.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized study, twenty adults with complete upper jaw tooth loss opposite natural lower teeth are assigned to a conventional workflow or a digital jaw-tracking workflow for fabricating screw-retained full-arch maxillary restorations. Occlusal accuracy will be measured with the OccluSense system, and patient satisfaction will be assessed with a visual analog scale after placement and during follow-up. The goal is to see if digital jaw tracking offers better bite relationships and more favorable patient-reported outcomes. The study compares dynamic jaw tracking and virtual articulation against static jaw relation records. Lead site is Mansoura University, with a focus on improving restorative workflow for edentulous patients.

Why it matters

Potential benefit: If successful, patients could experience more accurate occlusion and higher satisfaction with full-arch implant restorations.

How similar studies have gone: Prior work has explored digital occlusal analysis, with mixed but growing evidence supporting improved precision and patient-perceived outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female patients aged 50 to 70 years.
* Completely edentulous maxillary arch opposing natural mandibular dentition.
* Skeletal Class I maxillomandibular relationship with normal occlusion.
* Acceptable oral hygiene.
* Willing and able to provide written informed consent and comply with study procedures.

Exclusion Criteria:

* Systemic diseases affecting bone healing, such as uncontrolled diabetes mellitus or osteoporosis.
* Harmful oral habits, including smoking, clenching, or bruxism.
* Uncooperative patients or patients unable to comply with study procedures.

Where it's running

  • Faculty of Dentistry, Mansoura University
    Al Mansurah, Dakahlia Governorate, Egypt
    Recruiting

Study contacts

  • Principal investigator: Shahira S Mohamed, BDS — Faculty of Dentistry, Mansoura University
  • Study coordinator: Shahira s Mohamed, BDS
  • Email: shahirasaad@mans.edu.eg
  • Phone: +20 1004455178

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.